Chemical Component Summary

NameTOMUDEX
SynonymsZD1694; Raltitrexed
Identifiers(2S)-2-[[5-[methyl-[(2-methyl-4-oxidanylidene-1H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]carbonylamino]pentanedioic acid
FormulaC21 H22 N4 O6 S
Molecular Weight458.488
TypeNON-POLYMER
Isomeric SMILESCC1=NC(=O)c2cc(ccc2N1)CN(C)c3ccc(s3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
InChIInChI=1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1
InChIKeyIVTVGDXNLFLDRM-HNNXBMFYSA-N

Chemical Details

Formal Charge0
Atom Count54
Chiral Atom Count1
Bond Count56
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB00293 
NameRaltitrexed
Groups
  • approved
  • investigational
DescriptionRaltitrexed (brand name Tomudex®) is a chemotherapy drug manufactured AstraZeneca Company, is an antimetabolite used in chemotherapy. It is an inhibitor of thymidylate synthase.
Synonyms
  • Raltitrexed
  • Raltitrexed disodium
Brand NamesTomudex
IndicationFor the treatment of malignant neoplasm of colon and rectum
Categories
  • Antimetabolites
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Enzyme Inhibitors
  • Folic Acid Analogues
ATC-CodeL01BA03
CAS number112887-68-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Thymidylate synthaseMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDR...unknowninhibitor
Folylpolyglutamate synthase, mitochondrialMSRARSHLRAALFLAAASARGITTQVAARRGLSAWPVPQEPSMEYQDAVR...unknownantagonist
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL225071
PubChem 5281913, 104758, 135400182
ChEMBL CHEMBL225071
ChEBI CHEBI:5847